Dr. Aamer Farooq, MD

Dr. Farooq practices at Astera Cancer Care - East Brunswick in East Brunswick, New Jersey.

Dr. Farooq's NPI, 1518165919, was assigned on July 6, 2007. Dr. Farooq holds New Jersey license 25MA11809500.

Dr. Farooq's primary practice is Astera Cancer Care - East Brunswick, at 629 Cranbury Rd, East Brunswick, NJ 08816 in Middlesex County. The practice phone is (732) 390-7750.

Dr. Farooq's primary practice is Astera Cancer Care - East Brunswick in East Brunswick, New Jersey. Dr. Farooq is also affiliated with Robert Wood Johnson University Hospital. The medical group on file is Astera Cancer Care. Dmand AI also links Dr. Farooq to 3 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Farooq practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Farooq's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Farooq's licenses on file in 5 states: New Jersey, Arkansas, California, Florida and New York.

CMS data shows 3,957 Medicare services from Dr. Farooq across 21 procedure codes in 2024, for 481 Medicare patients. Medicare paid $234,984 for them.

CMS counts 481 Medicare patients who saw Dr. Farooq in 2024. The largest group is 75 to 84, with 193 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.39, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Farooq's median patient age at 65, with 62% women.

In 2024, Dr. Farooq wrote 794 Medicare Part D claims for 152 patients. 59% of them were for generic drugs. CMS names the drug for 435 of them, across 18 drugs with 11 or more claims each, at $1,015,384 in total drug cost. In 2023, CMS named 276 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Farooq for performance year 2024, reported as part of a group. Dr. Farooq accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Farooq as offering telehealth.

Dmand AI links 4 papers to Dr. Farooq in 2010. The most frequent topics are Carcinoma, Non-Small-Cell Lung, Lung Neoplasms and Adenocarcinoma. Dr. Farooq has published most often in J Thorac Oncol. Dr. Farooq's most frequent co-authors are Peter W. Bushunow, MD, Todd Demmy, MD and Grace K. Dy, MD.

Dmand AI links Dr. Farooq to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung and Carcinoma, Bronchogenic.

CMS Open Payments shows 682 general payments to Dr. Farooq from 77 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 53% of the total. Novocure Inc. paid the most, $5,791.